Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Clinical trial NCT04379999 · COMPLETED
Trial details
- NCT number
- NCT04379999
- Sponsor
- Fox Chase Cancer Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2025-08-04
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.